Promoter-Controlled Synthesis and Antigenic Evaluation of Mannuronic Acid Alginate Glycans of Pseudomonas aeruginosa

Org Lett. 2022 Nov 18;24(45):8381-8386. doi: 10.1021/acs.orglett.2c03439. Epub 2022 Nov 8.

Abstract

Pseudomonas aeruginosa is a leading cause of urinary tract, pulmonary, and wound infections and is becoming increasingly resistant to antibiotics. Here, we report the iodonium- and gold(I)-promoted bimodal glycosylation of glycosyl (Z)-ynenoates for highly β-selective promoter-controlled synthesis and antigenic evaluation of a series of 1,2-cis-β-linked mannuronic acid alginate glycans of P. aeruginosa up to a 24-mer, which represents the longest polymannuronic acid synthesized to date. By screening the six synthetic mannuronic acid alginate glycans with the mouse serum antibodies, we identified the mannuronic acid tetrasaccharide as the optimal antigen epitope for the development of vaccines against P. aeruginosa.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alginates
  • Animals
  • Hexuronic Acids
  • Mice
  • Pseudomonas Infections* / prevention & control
  • Pseudomonas aeruginosa*

Substances

  • mannuronic acid
  • Alginates
  • Hexuronic Acids